Brief: Eurazeo's Nov Santé Actions Non Cotées Fund Invests In Oncodesign Services

Eurazeo SE

23/01/2024 08:09

Jan 23 (Reuters) - Eurazeo SE  EURA.PA :
    * NOV SANTÉ ACTIONS NON COTÉES FUND INVESTS IN ONCODESIGN
SERVICES
    * NOV SANTÉ ACTIONS NON COTÉES FUND, MANAGED BY EURAZEO,
BOUGHT A
MINORITY STAKE IN ONCODESIGN SERVICES GROUP FOR EUR 22 MILLION,
ALONGSIDE MANAGEMENT AND ERES IV SLP
    * TRANSACTION RELATES TO ACQUISITION OF DUTCH COMPANY ZOBIO,
IN
PURSUIT OF ITS AIM OF BECOMING A CRO THAT OFFERS A FULL RANGE OF
PRE-CLINICAL RESEARCH SERVICES
    * NOV SANTÉ’S INVESTMENT HAS ENABLED ONCODESIGN SERVICES TO
FUND
THE ACQUISITION OF DUTCH COMPANY ZOBIO, WHICH SPECIALIZES IN
PRE-CLINICAL SMALL-MOLECULE RESEARCH
    * ACQUISITION WILL BOOST GROUP'S REVENUE TO EUR 44 MILLION
AND ITS
HEADCOUNT TO AROUND 280, INCLUDING AROUND 50 BASED IN LEIDEN IN
NETHERLANDS

Source text: shorturl.at/AQTUZ
Further company coverage:  EURA.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))